Cancer Immunotherapy: Individual mutations as new target structures

Interview with Prof. Ugur Sahin, founder and scientific managing director of TRON – Translational Oncology at the Mainz University Medical Center


Photo: Prof. Ugur Sahin

Prof. Ugur Sahin; ©private

Grafic: Syringe and DNA

Once the mutations have been determined, a personalized vaccine is being developed, which is injected to the patient in the inguinal lymph nodes; © /brijit vijayan

Photo: Simone Ernst; Copyright: B. Frommann

©B. Frommann